NL-OMON27467
Completed
Not Applicable
Observational study;<br>Bevacizumab, Radiotherapy and Temozolomide Safety study in biopsied or resected primary GBM patients.
Departments of Neurosurgery, Radiation Oncology, Clinical Oncology and NeurologyAcademisch Medisch CentrumMeibergdreef 151105 AZ Amsterdam+31 20 56691110 sites20 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- 1. Primary Glioblastoma Multiforme (NLD: primair Glioblastoma multiforme),
- Sponsor
- Departments of Neurosurgery, Radiation Oncology, Clinical Oncology and NeurologyAcademisch Medisch CentrumMeibergdreef 151105 AZ Amsterdam+31 20 5669111
- Enrollment
- 20
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients with histologically proven GBM (biopsy or resection);
- •2\. Can start 3\-8 weeks post biopsy or surgery;
Exclusion Criteria
- •1\. Age \<18 years;
- •2\. Pregnancy;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Bevacizumab in the Radiation Treatment of Recurrent Malignant GliomaBrain CancerRecurrent Malignant GliomasPrimary Brain TumorNCT00595322Memorial Sloan Kettering Cancer Center25
Terminated
Not Applicable
The Role of Bevacizumab in the Treatment of Radiation Necrosis in Children With Central Nervous System TumorsRadiation NecrosisNCT01201850University of Colorado, Denver7
Recruiting
Phase 2
Effect of Bevacizumab on Asymptomatic Radiotherapy-induced Brain InjuryBrain InjuriesNCT05303259Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University204
Completed
Phase 2
Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical CancerCervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedStage IB Cervical Cancer AJCC v6 and v7Stage IIA Cervical Cancer AJCC v7Stage IIB Cervical Cancer AJCC v6 and v7Stage III Cervical Cancer AJCC v6 and v7NCT00369122National Cancer Institute (NCI)60
Unknown
Phase 2
Preoporative Bevacizumab, Radiation Therapy, and XELOX Chemotherapy for Locally Advanced Nonmetastatic Rectal CancerRectal CancerNCT01818973Sun Yat-sen University45